GlassScriptPhysician profile
Edwin R England
NPI 1417068313
$571.25
in general payments reported to CMS, 2019-2025
16 companies · $96.56 in 2025
The $96.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.79 · 2020: $13.78 · 2021: $115 · 2022: $132 · 2023: $113 · 2024: $59.50 · 2025: $96.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $192.78 | 2021-2024 | |
| Pfizer INC. | $52.96 | 2020-2024 | |
| Coopersurgical, INC. | $50.51 | 2022-2025 | Ally II Ups |
| Hologic Sales and Service, LLC | $50.19 | 2021-2024 | Thinprep 2000 Processor |
| Exeltis, USA INC. | $36.66 | 2021-2023 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $27.29 | 2019-2021 | |
| Hologic INC | $23.71 | 2021 | |
| Biogen, INC. | $23.57 | 2025 | Zurzuvae |
| Inspire Medical Systems, INC. | $20.65 | 2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.47 | 2019 | |
| Sumitomo Pharma America, INC. | $14.67 | 2025 | Myfembree |
| Axonics, INC. | $13.78 | 2021 | |
| Shield Therapeutics INC | $12.91 | 2023 | Accrufer |
| Allergan, INC. | $12.91 | 2019 | |
| Ethicon US, LLC | $12.10 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $10.09 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin England listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.